Physician
Winona Health Services
Winona Health Services was paid $13.43M by Medicaid between Jan 2018 and Dec 2024, across 191 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 21% of everything it billed.
33Billing provider infoWINONA HEALTH SERVICES
WINONA, MN 55987
WINONA, MN 55987
33aNPI1295789352assigned 05/20/2006
33bProvider typeGeneral Practice Physician
28Total paid$13.43M
24GClaims378,326
24DCodes billed191
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Practice Physician providers in Minnesota
Rank by total paid#1 of 23
Median peer was paid$636K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 56,121 | $682K | |
| 2019 | 58,027 | $1.93M | |
| 2020 | 56,859 | $2.02M | |
| 2021 | 62,224 | $2.76M | |
| 2022 | 57,667 | $2.41M | |
| 2023 | 53,151 | $2.15M | |
| 2024incomplete | 34,277 | $1.48M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 70,729 | 60,153 | $2.79M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 16,534 | 13,061 | $1.82M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 27,285 | 24,170 | $1.51M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.0% | 16,045 | 12,996 | $1.21M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 8.2% | 19,278 | 16,813 | $1.11M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6.5% | 12,387 | 9,215 | $876K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.3% | 3,298 | 2,586 | $577K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.1% | 11,124 | 8,758 | $278K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.7% | 3,491 | 3,342 | $228K |
| 11721 | 1.3% | 10,679 | 8,531 | $181K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.3% | 2,920 | 2,513 | $172K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.1% | 9,031 | 8,332 | $142K |
179 more codes
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,197 | $132K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,739 | $129K |
| 36415 | Collection of venous blood by venipuncture | <1% | 40,528 | $128K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 2,070 | $123K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 2,263 | $121K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 3,256 | $116K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,832 | $114K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,110 | $96K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 2,891 | $94K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,256 | $91K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,035 | $86K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 745 | $82K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 610 | $75K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,969 | $74K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 877 | $62K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,076 | $58K |
| 92588 | <1% | 5,592 | $56K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 5,215 | $47K |
| 92015 | Determination of refractive state | <1% | 3,669 | $44K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 10,052 | $42K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,450 | $40K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 704 | $36K |
| 96127 | <1% | 7,978 | $35K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,014 | $30K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 607 | $27K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 282 | $25K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,816 | $25K |
| 80053 | Comprehensive metabolic panel | <1% | 5,797 | $24K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 155 | $24K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,511 | $24K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 453 | $20K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 687 | $19K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,621 | $17K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,017 | $17K |
| 81514 | <1% | 123 | $17K | |
| 80061 | Lipid panel | <1% | 1,667 | $15K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 691 | $15K |
| 83021 | <1% | 1,399 | $14K | |
| 0002A | <1% | 673 | $13K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,915 | $13K |
| 99188 | <1% | 997 | $13K | |
| 0001A | <1% | 701 | $13K | |
| 91320 | <1% | 179 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 500 | $11K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 82 | $10K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 235 | $10K |
| 99348 | <1% | 165 | $9K | |
| 71045 | Radiologic examination, chest; single view | <1% | 796 | $9K |
| 99349 | <1% | 94 | $9K | |
| 90480 | <1% | 362 | $9K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 503 | $8K |
| 99173 | <1% | 4,651 | $8K | |
| 86769 | <1% | 355 | $8K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 12 | $7K |
| 90837 | Psychotherapy session, about an hour | <1% | 142 | $7K |
| 90686 | <1% | 3,184 | $7K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 383 | $7K |
| 62323 | <1% | 12 | $7K | |
| 99307 | <1% | 389 | $6K | |
| 99335 | <1% | 95 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 268 | $6K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 93 | $6K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 268 | $5K |
| X5622 | <1% | 81 | $5K | |
| G0008 | Administration of influenza virus vaccine | <1% | 331 | $5K |
| 0064A | <1% | 321 | $5K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 41 | $5K |
| 90677 | <1% | 55 | $5K | |
| 99442 | <1% | 184 | $4K | |
| S0281 | Medical home program, comprehensive care coordination and planning, maintenance of plan | <1% | 194 | $4K |
| 97803 | <1% | 138 | $4K | |
| 90670 | <1% | 806 | $4K | |
| 0004A | <1% | 186 | $4K | |
| 0134A | <1% | 181 | $4K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 84 | $4K |
| 82728 | <1% | 261 | $3K | |
| 99223 | Prolong inpt eval add15 m | <1% | 27 | $3K |
| 90662 | <1% | 88 | $3K | |
| 87205 | <1% | 450 | $3K | |
| 0072A | <1% | 109 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 299 | $3K |
| 87808 | <1% | 302 | $2K | |
| 99441 | <1% | 181 | $2K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 133 | $2K |
| 85610 | <1% | 1,170 | $2K | |
| 0071A | <1% | 79 | $2K | |
| 97597 | <1% | 60 | $2K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 983 | $2K |
| 86140 | <1% | 294 | $2K | |
| 90682 | <1% | 69 | $2K | |
| 0124A | <1% | 80 | $2K | |
| 87210 | <1% | 315 | $2K | |
| 97161 | <1% | 33 | $1K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 13 | $1K |
| 0054A | <1% | 48 | $1K | |
| 92557 | <1% | 42 | $1K | |
| 85027 | <1% | 198 | $1K | |
| 90473 | <1% | 182 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 466 | $1K |
| 83605 | <1% | 336 | $1K | |
| 80076 | <1% | 299 | $881.52 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 45 | $855.10 |
| 90656 | <1% | 246 | $841.99 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 25 | $839.55 |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | <1% | 75 | $779.56 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 337 | $766.10 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 14 | $689.89 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12 | $685.72 |
| 73030 | <1% | 30 | $670.53 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 37 | $668.33 |
| 86592 | <1% | 72 | $594.08 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 13 | $581.79 |
| 99217 | <1% | 14 | $511.49 | |
| J2704 | Injection, propofol, 10 mg | <1% | 770 | $509.18 |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 27 | $439.56 |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | <1% | 18 | $403.03 |
| 99443 | <1% | 22 | $384.96 | |
| 88304 | <1% | 52 | $383.86 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 33 | $332.74 |
| 99490 | Ccm add 20min | <1% | 76 | $288.68 |
| 83735 | <1% | 267 | $286.17 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 644 | $285.32 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 368 | $284.25 |
| 92567 | <1% | 49 | $283.57 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $279.94 |
| 76830 | Ultrasound, transvaginal | <1% | 12 | $273.11 |
| 88142 | <1% | 38 | $242.30 | |
| 84145 | <1% | 35 | $240.22 | |
| 86780 | <1% | 13 | $183.14 | |
| 84484 | <1% | 62 | $179.91 | |
| 87631 | <1% | 12 | $157.50 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 103 | $143.36 |
| 81000 | <1% | 133 | $121.40 | |
| 99406 | <1% | 14 | $116.50 | |
| 73630 | <1% | 51 | $109.94 | |
| 86703 | <1% | 13 | $107.98 | |
| 80305 | <1% | 12 | $101.40 | |
| 84703 | <1% | 16 | $98.07 | |
| Q2036 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | <1% | 47 | $95.51 |
| 73564 | <1% | 38 | $89.96 | |
| 82077 | <1% | 15 | $87.34 | |
| 87653 | <1% | 13 | $86.60 | |
| 87899 | <1% | 13 | $82.63 | |
| 73610 | <1% | 30 | $71.23 | |
| 81001 | <1% | 41 | $62.92 | |
| 85730 | <1% | 54 | $59.14 | |
| 82043 | <1% | 12 | $54.30 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 49 | $49.41 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 14 | $49.13 |
| 83690 | <1% | 70 | $45.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 474 | $44.73 |
| 81025 | <1% | 14 | $44.15 | |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 3,890 | $24.11 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 50 | $12.21 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 26 | $9.26 |
| 90648 | <1% | 800 | $8.99 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 15 | $5.52 |
| 81002 | <1% | 13 | $3.48 | |
| 90723 | <1% | 191 | $0.01 | |
| 90680 | <1% | 161 | $0.01 | |
| 90633 | <1% | 176 | $0.01 | |
| 1111F | 0% | 1,467 | $0.00 | |
| 1123F | 0% | 27 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 58 | $0.00 |
| A4217 | Sterile water/saline, 500 ml | 0% | 18 | $0.00 |
| 90651 | 0% | 54 | $0.00 | |
| 91319 | 0% | 14 | $0.00 | |
| 2023F | 0% | 12 | $0.00 | |
| 0501F | 0% | 12 | $0.00 | |
| 86580 | 0% | 15 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 1,201 | $0.00 |
| 0502F | 0% | 1,275 | $0.00 | |
| 1124F | 0% | 127 | $0.00 | |
| 90734 | 0% | 17 | $0.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 68 | $0.00 |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 13 | $0.00 |
| 90715 | 0% | 13 | $0.00 | |
| 90685 | 0% | 14 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHULTZ, RACHELLE (CEO)
| Provider | Location | Paid |
|---|---|---|
| Winona Health Services | Winona, MN | $1.00M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.